Clinical Insight into Type 2 Diabetes Mellitus: A Retrospective Study from Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia’s Teaching Hospital
DOI:
https://doi.org/10.31344/ijhhs.v8i40.746Keywords:
Type 2 Diabetes Mellitus, Personalized treatment, Demographic and Clinical, Diabetes-related complicationsAbstract
Objectives: This retrospective study aims to provide comprehensive clinical, complications and demographic insight into the management and outcomes of T2DM patients at Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia’s Teaching Hospital. Methods: The study analyzed medical records of T2DM patients from January 2020 to August 2024, focusing on patient demographics, glycemic control, diabetes-related complications, and treatment regimens. Statistical analysis were performed to identify correlations between patient characteristics and clinical outcomes. Results: A total of 355 patient records were reviewed, encompassing a diverse patient population with 55.7% male and a mean age of 61.3 years. More than 60% of the total patients presented with a history of hypertension, and 30.9% had dyslipidemia. As measured by HbA1c levels, glycemic control showed that only 40% of patients achieved the target of <7.0%, where diabetic retinopathy was observed in 27.6% of patients, nephropathy in 22.5%, and neuropathy in 20%. Pharmacological management predominantly included metformin (77%), followed by sulfonylureas (59%), and newer agents such as SGLT2i (32%) and GLP-1 Ra (24%). Insulin therapy was initiated in 33% of the cases, primarily in those with poor glycemic control or long-standing diabetes. Lifestyle interventions, though recommended, were suboptimal, with less than 20% of patients adhering to structured diet and exercise programs. Conclusion: The findings underscore the challenges in achieving optimal glycemic control and the high burden of diabetes-related complications among T2DM patients at HSAAS. The study calls for enhanced patient education, more aggressive management strategies, and the incorporation of newer antidiabetic agents to improve clinical outcomes, which serves as a crucial step in understanding the local epidemiology of T2DM and highlights the need for tailored interventions to address this growing healthcare burden.
International Journal of Human and Health Sciences Supplementary Issue 02: 2024 Page: S12
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:
- Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.
Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.
